These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9868029)

  • 1. [The plasma levels of endothelin in diabetic retinopathy and their changes after treatment with doxium].
    Zhong H; Guo L
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(1):56-8. PubMed ID: 9868029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof].
    Zhu H; Shi CH
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2837-9. PubMed ID: 18167288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperviscosity in diabetic retinopathy treated with Doxium (calcium dobesilate).
    Barras JP; Graf C
    Vasa; 1980; 9(2):161-4. PubMed ID: 7456667
    [No Abstract]   [Full Text] [Related]  

  • 4. [Endothelium and diabetes: study of plasma levels of endothelin-1 in diabetic patients with arterial hypertension or proliferative retinopathy].
    Parlapiano C; Paoletti V; Campana E; Rota C; Donnarumma L; Musca A; Andreani D
    Minerva Med; 1995 Mar; 86(3):105-20. PubMed ID: 7603606
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutical action of Doxium (calcium-dobesilate) in diabetic retinopathy].
    Zygulska-Machowa H; Maciejewski Z; Szopińska-Cibowa L; Pasadyn J; Bryk E
    Klin Oczna; 1976 Jun; 46(6):633-8. PubMed ID: 966623
    [No Abstract]   [Full Text] [Related]  

  • 6. [Significance of increased endothelin level for development of sequelae of diabetes mellitus].
    Haak T; Jungmann E; Hillmann U; Felber A; Usadel KH
    Med Klin (Munich); 1993 May; 88(5):291-6. PubMed ID: 8326915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of the diabetic retinopathy with doxium-clofibrate (author's transl)].
    Freyler H; Egerer I
    Klin Monbl Augenheilkd; 1976 Mar; 168(3):377-86. PubMed ID: 787642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium dobesilate: pharmacological profile related to its use in diabetic retinopathy.
    Berthet P; Farine JC; Barras JP
    Int J Clin Pract; 1999 Dec; 53(8):631-6. PubMed ID: 10692760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium dobesilate attenuates vascular injury and the progression of diabetic retinopathy in streptozotocin-induced diabetic rats.
    Padilla E; Ganado P; Sanz M; Zeini M; Ruiz E; Triviño A; Ramírez AI; Salazar JJ; Ramírez JM; Rojas B; Hoz Rd; Tejerina T
    Diabetes Metab Res Rev; 2005; 21(2):132-42. PubMed ID: 15386814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic retinopathy and long-term therapy with Doxium 52 patients treated over periods ranging from 5--9 years.
    Sevin R; De Courten A
    Bull Ophthalmol Soc Egypt; 1978; 71(75):309-21. PubMed ID: 549725
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long term treatment of diabetic retinopathy with doxium].
    Sévin R
    Ther Ggw; 1978 Dec; 117(12):1963. PubMed ID: 725811
    [No Abstract]   [Full Text] [Related]  

  • 12. What is new about the treatment of diabetic retinopathy by calcium dobesilae (Doxium).
    Cuendet JF; Sevin R
    Bull Ophthalmol Soc Egypt; 1976; 69(73):469-74. PubMed ID: 1031108
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of calcium dobesilate (Doxium) on blood viscosity and coagulation parameters in diabetic retinopathy.
    Vinazzer H; Hachen HJ
    Vasa; 1987; 16(2):190-2. PubMed ID: 3300085
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of calcium dobesilate on progression of diabetic retinopathy].
    Haas A; Trummer G; Eckhardt M; Schmut O; Uyguner I; Pfeiffer KP
    Klin Monbl Augenheilkd; 1995 Jul; 207(1):17-21. PubMed ID: 7564132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial.
    Haritoglou C; Gerss J; Sauerland C; Kampik A; Ulbig MW;
    Lancet; 2009 Apr; 373(9672):1364-71. PubMed ID: 19376452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of adrenomedullin, a vasoactive peptide, in type 2 diabetic patients with and without retinopathy.
    Caliumi C; Balducci S; Petramala L; Cotesta D; Zinnamosca L; Cianci R; Di Donato D; Vingolo EM; Fallucca F; Letizia C
    Minerva Endocrinol; 2007 Jun; 32(2):73-8. PubMed ID: 17557032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the diagnostic value of plasma endothelin for diabetic retinopathy using the receiver operating characteristic curve.
    Zhu H; Shi CH
    Ophthalmic Res; 2007; 39(5):289-93. PubMed ID: 17851270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The relationship of methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in type 2 diabetes mellitus patients with diabetic retinopathy].
    Sun J; Xu Y; Zhu Y; Lu H; Deng H; Fan Y; Sun S; Zhang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):131-4. PubMed ID: 12673582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical trial of Doxium tolerance].
    Schwaar R
    Rev Med Suisse Romande; 1971 Feb; 91(2):127-30. PubMed ID: 5579010
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood levels of total homocysteine in patients with type 1 diabetes (with no complications, diabetic nephropathy and/or retinopathy) and in their non-diabetic relatives.
    Matteucci E; Rossi L; Mariani S; Fagnani F; Quilici S; Cinapri V; Giampietro O
    Nutr Metab Cardiovasc Dis; 2002 Aug; 12(4):184-9. PubMed ID: 12514938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.